How to research a manufacturer across FDA names
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Medical-device intelligence
Research Hillcrest Biologicals in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.
This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.
33 clearance records and 0 recall records in the covered releases, across 1 source company names and 23 product codes. Dated history runs from Apr 5, 1983 to Dec 3, 1992.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 0 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| ARBOVIRUS IGG IFA TESTK913617 · GQC | Hillcrest Biologicals | 510(k) | Dec 3, 1992FDA decision date |
| ARBOVIRUS IGM IFA TESTK913618 · GQC | Hillcrest Biologicals | 510(k) | Dec 3, 1992FDA decision date |
| Q FEVER IGG IFA TESTK913906 · GPJ | Hillcrest Biologicals | 510(k) | Oct 21, 1992FDA decision date |
| Q FEVER IGM IFA TESTK922374 · GPJ | Hillcrest Biologicals | 510(k) | Oct 21, 1992FDA decision date |
| LYME DISEASE IGM ELISAK900206 · LSR | Hillcrest Biologicals | 510(k) | Jun 28, 1991FDA decision date |
| EBV VCA ANTIBODY (IGM)K896594 · LJN | Hillcrest Biologicals | 510(k) | Jan 16, 1990FDA decision date |
| EBV EARLY ANTIGEN (R+D)K884829 · JRY | Hillcrest Biologicals | 510(k) | Apr 12, 1989FDA decision date |
| LYME DISEASE IFA (IGM)K883767 · LSR | Hillcrest Biologicals | 510(k) | Mar 15, 1989FDA decision date |
| EBV-VCA ANTIBODY (IGG)K884591 · GNP | Hillcrest Biologicals | 510(k) | Jan 24, 1989FDA decision date |
| LYME DISEASE IFA (IGG)K883487 · LSR | Hillcrest Biologicals | 510(k) | Dec 13, 1988FDA decision date |
| EBNA ANTIBODYK875170 · LLM | Hillcrest Biologicals | 510(k) | May 23, 1988FDA decision date |
| LYME DISEASE ELISAK880476 · LSR | Hillcrest Biologicals | 510(k) | Apr 26, 1988FDA decision date |
| LEPTOSPIROSIS IHAK880417 · GRY | Hillcrest Biologicals | 510(k) | Apr 12, 1988FDA decision date |
| RICKETTSIAL IGG AND IGM IFA KITK864110 · GPN | Hillcrest Biologicals | 510(k) | Mar 12, 1987FDA decision date |
| TRANSPORT CULTURE MEDIAK854715 · JSM | Hillcrest Biologicals | 510(k) | Dec 23, 1985FDA decision date |
| ECHO TYPE 16 CF ANTIGENK853156 · GNK | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| ECHO TYPE 11 CF ANTIGENK853157 · GNK | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| ECHO TYPE 30 CF ANTIGENK853165 · GNK | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| CMV CF ANTIGENK853277 · GQI | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| POLIO TYPE I CF ANTIGEN, & TYPE II, IIIK853278 · GOG | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| COXSACKIE A2 CF ANTIGEN, A4, A10 & A16K853279 · GNO | Hillcrest Biologicals | 510(k) | Nov 7, 1985FDA decision date |
| CMV-IHAK852494 · LJO | Hillcrest Biologicals | 510(k) | Sep 16, 1985FDA decision date |
| HILLCREST AMEBIASIS IHA TESTK853448 · KHW | Hillcrest Biologicals | 510(k) | Aug 28, 1985FDA decision date |
| HERPES SIMPLEX GROUP CF ANTIGENK850609 · GQN | Hillcrest Biologicals | 510(k) | May 9, 1985FDA decision date |
| CELL CULTURE REFEED MEDIUMK850537 · KIT | Hillcrest Biologicals | 510(k) | Mar 20, 1985FDA decision date |
Check applicant and recalling-firm names without confusing spelling variations, subsidiaries, and unrelated companies.
Read the guide →Build a repeatable clearance search using FDA applicant names, product codes, decision dates, and original records.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.